Wuhan Chuangside Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Wuhan Chuangside Technology Co., Ltd. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. Currently, 11 trademarks are registered. Notable registered marks include IMOLAZA, SENOSUR, STRUSTNETY, CYCLE & SOAK, and INTELLIGENT ET MASTER. The owner is based in Wuhan.
Rm.B341,4F,Bldg.1,Guoji Qiye Zhongxin
Donghu New Technology Development Zone
Wuhan 430000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wuhan Chuangside Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Wuhan Chuangside Technology Co., Ltd. have?
Wuhan Chuangside Technology Co., Ltd. has 12 U.S. trademarks filed with the USPTO. Of these, 11 registered, 1 abandoned.
What trademark classes does Wuhan Chuangside Technology Co., Ltd. file in?
Wuhan Chuangside Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Wuhan Chuangside Technology Co., Ltd.'s most well-known trademarks?
Wuhan Chuangside Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as IMOLAZA, SENOSUR, STRUSTNETY, CYCLE & SOAK, and INTELLIGENT ET MASTER. These are among 11 currently registered trademarks in the portfolio.
What is Wuhan Chuangside Technology Co., Ltd.'s trademark registration success rate?
Wuhan Chuangside Technology Co., Ltd. has a 92% trademark registration rate, with 11 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.